Argus Research Maintains Buy on Colgate-Palmolive, Raises Price Target to $107
Portfolio Pulse from Benzinga Newsdesk
Argus Research has maintained its Buy rating on Colgate-Palmolive (NYSE:CL) and raised the price target from $97 to $107, indicating confidence in the company's future performance.
May 15, 2024 | 4:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Argus Research has maintained its Buy rating on Colgate-Palmolive and raised the price target from $97 to $107, reflecting a positive outlook on the company's future performance.
The raised price target from $97 to $107 by Argus Research suggests increased confidence in Colgate-Palmolive's future performance. This is likely to positively impact the stock price in the short term as investors react to the upgraded target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100